Cadila Healthcare, a Rs. 9,450 crore plus pharma major and its subsidiary Zydus Pharmaceuticals (USA) Inc., have finalized an agreement with Kowa Company Ltd, Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries Ltd to settle all outstanding patent litigation related to Livalo (pitavastatin calcium) tablets.